Joint Meeting of the Société de Néphrologie, the Italian Society of Nephrology, and the Spanish Society of Nephrology  by unknown
Kidney International, Vol. 31 (/987), pp. 1416—1419
Abstracts
Joint Meeting of the Société de Nephrologie,
the Italian Society of Nephrology,
and the Spanish Society of Nephrology
Barcelona, October 24—25, 1986
Discrepancy in light chain disease (LCD). B Hurault de Ligny, X
Troussard, B Gallet, JPh Ryckelynck, B Levaltier, JC Mandard, M
Leporrier, Service de Néphrologie, Service d'Hematologie, Service
d'Anatomopathologie, CHU Caen, 14033 Caen Cédex, France. LCD is
characterized by widespread tissue deposition of a material which is
reactive with anti-light chain sera and lacks the characteristics of
amyloid. We describe three cases which disclose the histologic discrep-
ancy of this disease. CASE 1: a 72-year--old woman presented with a
nephrotic syndrome associated with renal failure and stage ILL/B
multiple myeloma (MM). Renal biopsy disclosed non-amyloid kappa
granular—deposits in the glomeruli. With chemotherapy, 13 months later
the disease was stable. CASE 2: a 72-year—old woman was admitted
because of rapidly—progressive renal failure associated with stage I/B
MM. Ten months after the diagnosis, the patient died with fulminant
hepatic failure. Immunofluorescent studies in the kidney showed kappa
granular deposits along the glomerular and tubular basement mem-
branes. Moreover, a characteristic green birefringence with Congo red
was detected in small arteries. At the ultrastructural level, granular and
fibrillar structures were present: the amyloid fibrils were 10 nm in
diameter and randomly oriented; the non-amyloid fibrils were 18 nm
arranged in parallel, and present in numerous tissues. CASE 3: a
70-year—old man presented with nephrotic syndrome. MM was not
detected. Despite chemotherapy, the patient died two months later with
renal failure. Renal biopsy showed glomerular and peritubular lambda
deposits. Electron microscopy detected granular and fibrillar patterns.
The fibrils were non-amyloid, arranged in parallel, and diffuse (kidney,
skin, liver). The three cases disclose the discrepancy of the LCD: the
association with MM (cases 1, 2) or amyloidosis (case 2); kappa (cases
1, 2) or lambda (case 3) light chain deposits; glomerular (case 1) and
peritubular (cases 2, 3) granular (case 1) and fibrillar (cases 2, 3)
deposits. Immunomicroscopy for immunoglobulin light chains was
performed on all biopsy specimens; possible prognostic and therapeutic
implications of the delineation of LCD require further evaluation and
follow—up.
Continuous ambulatory peritoneal dialysis—transplantation program in
insulin-dependent dIabetics. C Mousson, Y Tanter, JM Chalopin, G
R(fle, Département de Nephrologie et Reanimation, CHU du Bocage,
21034 DUon, France. A program of continuous ambulatory peritoneal
dialysis (CAPD)-transplantation has been established in young
insulin—dependent diabetics (IDD) since 1982. We report our results up
to the end of 1985. This study included 9 patients, 5 males and 4
females. Age range was 9 to 45 years (mean 34.6). The 9-year-old girl
had cystinosis. The duration of diabetes ranged from 7 to 29 years
(mean 20.2). All patients had many complications: 9 severe retinopa-
thies (2 blindness), 9 neuropathies, 3 arteritis, 4 ischemic heart disease.
4 of them had cutaneous infections when starting dialysis. Mean
creatinine clearance was 6 mi/mn (range 5 to 10 mI/mn). Dextrose
concentration of dialysate was selected according to the ultrafiltration
required. Insulin was added to dialysate in the 4 daily exchanges. All
the patients received at least 10 units of packed red blood cells.
Conventional immunosuppressive regimen (corticosteroids, azathio-
prine, antilymphocyte globulins) was begun immediately after trans-
plantation. Since 1984 ciclosporin has been substituted after the third
month. One 36-year-old man refused CAPD and was transplanted 8
months fte.r sthrtino hemodialvsis. Eleven months later serum creati-
nine level (SCL) was 195 mol/liter. His right foot was amputated after
grafting because of arteriopathy. In the 8 other patients treated by
CAPD, incidence of peritonitis was 1 episode every 8.9 patient—months.
Control of blood glucose level was better during CAPD. Glycosylated
hemoglobin values decreased in all patients: before starting CAPD,
mean value was 11% (N < 6.6%) and only 7.3% 6 months after
beginning CAPD. Two patients died before transplantation (I suicide, 1
sudden death in a patient who had ischemic heart disease). One patient
is still waiting for transplantation 37 months after starting CAPD. Five
patients were transplanted with cadaver donor kidney after 3 to 27
months (mean 13.6) of CAPD treatment. None had cutaneous infection
at the time of transplantation. Diuresis began rapidly in all 5 patients.
Peritoneal catheter was removed between days 16 and 29 (mean 21). All
these patients had a functioning graft 3 to 54 months (mean 17.6) after
transplantation. SCL range was 65 to 180 mol/1iter (mean 153). Five
rejection episodes in 3 patients were successfully treated by methyl-
prednisolone pulses. No mechanical or infectious complications due to
CAPD were observed. Nevertheless, I sepsis, 1 urinary fistula due to
ureteral necrosis and 3 urinary tract infections occurred. Conclusion:
these results seem encouraging enough to pursue this program further.
Is idiopathic nephrotic syndrome (INS) a food allergy? The significance
of oligo-antigenic diet. G Lagrue, J Laurent, C Bruneau, J Sainte—
Laudy, Service de Nephrologie, Hôpital Henri Mondor, 94010 Créteil,
France. The role of allergy in INS is now well documented; the
responsibility of inhalant allergans has been demonstrated in several
cases. Cases with food allergy have been rarely reported. Sandberg
(Lancet, 1977, i:388—39l) demonstrated the responsibility of cow's milk
in INS in children; later we observed frequent food allergen sensitisa-
tion by the Human Basophil Degranulation Test (HBDT—Nephron
1986, 42:123—127). Allergy can only be confirmed by avoidance or
provocation tests, Like Egger in migraine (Lancet 1983, ii:865—869), we
used for 10 days an oligo-antigenie diet in 13 INS who failed on steroid
therapy (5 corticodependent, 5 multiple relapsers, 3 corticoresistant).
The 5 to 6 allowed foods were chosen according to skin tests, specific
IgE (RAST) and HBDT. A history of allergy was present in 8 cases and
an increase in serum IgE levels in 6. Sensitivity to food antigens was
documented by skin tests in 5, by RAST in 5 and by HBDT in 11. The
proteinuria of the 13 patients (initially > 5 glday) were significantly
reduced at the end of the oligoantigenic diet as compared to the initial
levels. They decreased by more than 50% in 9 patients and disappeared
completely in 5 of them. The positivity of the oligoantigenic diet
demonstrated the role of food allergens and suggests long—term trial of
specific food avoidances. Identification of the responsible food(s) is
very difficult, however, and so far has been successful only in few
cases.
Goodpasture's syndrome: Special aspects and therapeutic propositions.
G Rifle, C Mousson, Y Tanter, E Justrabo, JM Chalopin, Department
of Nephrology and Reanimation, Department of Pathology, Dijon,
France. The frequency of Goodpasture's syndrome (GP) has perhaps
increased in France. In our Departments we observed 4 cases in less
than one year. It can appear with unusual symptomatology and the most
severe glomerulonephritides still pose unresolved therapeutic prob-











I 23/F 52 250 80 +
2 22/M 62 650 40 +
3 39/F 60 anuria 100 +
4 23/F 15 88 43 +
N 12.8% (radioimmunoassay); SCL, serum creatinine level
Patients 1 and 2 at presentation both had a total spectrum of lung
hemorrhages with alveolar syndrome and rapidly—progressive renal
failure. But patient 3 who had Down's syndrome and severe pulmonary
tuberculosis sequellae, initially presented acute respiratory—distress
syndrome (ARDS) with lung hemorrhage without known cause. She
required mechanical ventilation 7 months before having anuric acute
renal failure associated with recurrent lung hemorrhages. Her ARDS
improved without corticosteroid (CS) or immunosuppressive drugs
(IS). Patient 4 had only glomerular proteinuria (3 g/day) and macro-
scopic hematuria, without renal failure. Meticulous questioning re-
vealed some blood spitting 3 years before and only 2 weeks before
admittance. Patient 4 was treated only with CS (1 mg/kg/day) and
cyclophosphamide (2 mg/kg/day) for 9 months. Anti-GBM antibodies
Ab disappeared as did urinary symptoms (follow—up 9 months). Control
renal biopsy 6 months alter starting therapy showed no more crescents.
For the 3 others we decided to put into practice a new therapeutic
protocol because of poor prognosis of the most severe glomerulo-
nephritides (SCL 600 mol/liter, more than 80% of crescents and
especially anuria), Our protocol associates Lockwood's regimen
(plasma exchange [PE], CS and IS) and 3 methylprednisolone pulses of
15 mg/kg/day for 3 days. This protocol is closely related to that used in
non antibody—mediated extracapillary glomerulonephritis (Proc EDTA







1 36 14 90
2 38 14 130
3 33 6 550
No side effects were observed, whereas patient 3 had a high risk of
infectious complications. Lung hemorrhages rapidly disappeared. Im-
provement of renal function in such a severe form as those of patient 3
had never been observed by Lockwood. Therefore the pursuit of this
trial seems to be justified.
Chronic interstitial nephritis in patients with analgesic abuse and the
development of malignant tumors of the kidney and ureter. W Lornoy, I
Becaus, V Morelle, E Fonteyne, L Thienpondf, J Mestdagh, A Rollier,
R Van Steenberge, P D'Haenens, Departments of Nephrology, Urol-
ogy, Pathology and Radiology, O.L. Vrouwziekenhuis, B-9300 AALST,
Belgium. In 12 years 412 patients with chronic interstitial nephritis due
to prolonged analgesic abuse (NAA) were seen in our hospital. Among
these, 39 patients developed a malignant tumor of the kidney and/or the
ureter:
—20 patients with a tumor of the renal pelvis
—7 patients with a ureteral tumor
—5 patients with a tumor of both renal pelvis and ureter
—5 patients with a renal cell carcinoma
—l patient with a bilateral tumor of the renal pelvis
—1 patient with a tumor of the renal pelvis and a renal cell carcinoma
in the contralateral kidney.
This means that 8% of the patients with NAA have developed a
urothelial tumor and 1.43% a renal cell carcinoma. Among these 39
patients, 90% were women. The mean age was 62 years (40 to 75). The
mean serum creatinine was 4 mg% (I to 12 mg%), while in the patients
with renal cell carcinoma the mean serum creatinine was 8.8 mg% (3 to
12 mg%). Seven patients were treated with hemodialysis and 1 with
CAPD. The outcome was poor. Twenty—seven patients died: 11 pa-
tients with metastasis and 16 with renal or cardiac failure. The percent-
age of malignant tumors in patients with NAA shows an increased risk
not only to develop a urothelial tumor, but also a renal cell carcinoma.
Indeed, taking into account the occurrence of a renal cell carcinoma in
the general population and the sex ratio, the incidence of a renal cell
carcinoma in NAA is highly significant (P < 0.005).
Evaluation of plasma total and free 1,25(OH)2 vitamin D3 in calcium
stone formers. P Bataille, R Bouillon, A Fournier, H Renaud, A Idrissi,
CHU Amiens, France, Clinique St Rafael, Louvain, Belgium. The
following determinations were performed in 12 controls (C) and in 51
calcium stone formers: 24 hour calciuria on free diet; alter 4 days of
calcium restricted diet (CaRD); 24 hour calciuna, fasting urinary
calcium/creatinine ratio, fasting plasma concentrations of calcium,
phosphate, PTH, total 1,25(OH)2D3; D binding protein (DBP); and P
PTH 4 hours alter a calcium load of I g. The results of the 4 first
parameters in controls allowed the classification of the calcium stone
formers into normocalciuna (NCa), dietary hypercalciuria (DH) and
idiopathic hypercalciuria, which was subclassified into 3 categories:
absorptive (AH), renal (RH) and undetermined idiopathic hypercal-
ciuria (UH).













diet CaRD Cr alter D3 DBP DBP P04
mmol/ mmol/ mmol/ Ca pg/ ng/ ratio mmol/
kg kg mmol loadc ml ml X l0 liter
C 0.1 0.07 0.3 N/N 50 390 1.75 1.05




































Significance of the difference versus controls a p < .01, b p < .001,
PTH; N = normal, d increased. Conclusions. I.) P 1 ,25(OH)2D3 is
increased in AH and UH the 2 subgroups of idiopathic hypercalciuria
without secondary hyperparathyroidism. 2.) Since a negative correla-
tion (r =
—0.87, P < 0.01) is found in the AH group between P
1 ,25(OH)2D3 and PPO4, this increase of P 1 ,25(OH)2D in AH may be
explained by a primary tubular leak of P04. 3.) In UH, lack of
correlation of P I ,25(OH)2D with any of the other parameters suggests
a primary dysregulation of I ,25(OH)2D3 synthesis in this group.
Destructive spondylarthropathies of hemodialysis patients is associated
with amyloidosis reacting with anti-$2 microglobulin antiserum. G
Lambrey, JL Sebert, TBardin, T Shirahama, A Marie, JD Gheerbrand,
P Moriniere, D Kuntz, J Zingraff, A Fournier, CHU, Amiens, France;
Centre Viggo Petersen, Paris; University of Boston, Massachusetts,
USA; (4) Hopital Necker, Paris, France. The pathophysiology of
destructive spondylarthropathies (DS), which has been recently de-
scribed hemodialysis (HD) patients (Arthritis Rheum. 27 369—375,
1984), is still poorly understood. We performed a pathological study in
4 patients (2 males, 2 females, ages 52 to 64) with nonamyloid
nephropathies who developed severe disk narrowing and erosions of
adjacent vertebral plates, characteristic of DS. These lesions appeared
alter 10 to 12 years of maintenance HD treatment and were located in
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the cervical spine of the 4 patients and also in the lumbar spine of one.
Two patients were operated because of persistent radiculopathy and
one because of cervical cord compression. Tissues from the fourth
patient were obtained at autopsy. Amyloid deposits were characterized
by their Congo red—induced green birefringence in disc and/or vertebral
ligaments of the 4 patients. Deposits were sensitive to potassium
permanganate treatment. Transmission electron microscopy study,
which was performed in 2 patients, demonstrated the fibrillar ultrastruc-
ture of the deposits and disclosed clusters of apatite crystals in one disc
specimen. By the avitin—biotin peroxidase complex method, deposits
were shown to react moderately with anti-human AP antiserum and
strongly with anti-human 13z microglobulin antibody. They did not react
with anti-AA protein antiserum. Conclusion. This study shows that
destructive spondylarthropathies of HD patients is associated with local
amyloid deposits which react with anti-i3 microglobulin antiserum.
Further studies are needed to understand the respective role of apatite
deposition and f3 microglobulin retention in the genesis of these
lesions,
C3a anaphylatoxin generation by blood tubings: Comparison of dif-
ferent materials. B Branger, G Baudin, C Granolleras, L Durand, R
Oulès, Nephrology Department and Radioimmunology Laboratory,
University Hospital, Nimes, France. In the field of biocompatibility,
few studies have been done on blood tubings. We analyzed C3a
anaphylatoxin generation, measured by radioimmunoassay, in 6
chronic hemodialyzed patients and 4 patients undergoing therapeutic
apheresis. The protocol consisted of extracorporeal circulation during
half an hour in a circuit composed exclusively by arterial and venous
blood tubings. The circuit temperature was maintained constant by a
thermostated heater. Blood flow was 250 mI/mm and heparin adminis-
tration was 80 lU/kg given in bolus intravenously before the procedure.
Blood tubings were similar in length (8 m) and internal surface 0.108 m2,
but were made of different materials: high—quality medical grade
di-ethyl-hexyl-phtalate plastifled polyvinyl chloride (PVC), poly-
urethane coextruded polyvinyl chloride (Ply), trimellitic esther plasti-
fled polyvinyl chloride (CR!) and LT 360 plastifled polyvinyl chloride
(LTP). Blood samples were taken at 0, 5, 15, 30 minutes on the arterial
blood line and on the venous blood line, close to the vascular connec-
tion. C3a generation rate (CGR) was calculated according to the
formula: CGR = Plasma flow x (venous concentration—arterial concen-
tration). Results are expressed as mean I standard deviation.
PVC /.Lg/min 6.12 25.06a
PIV 36.3 11.31
CR! (N = 3) 69.2 43.67
LTP (N = 3) 42.3 16.82
a P < 0.05 Student's t -test.
(RF) is debated. Because THP (synthesized by cells of the thick
ascending limb of Henle's loop) had been demonstrated in the glomer-
ular urinary space (GUS) in nephropathies related to urinary tract
obstruction, we decided to search for THP in glomeruli of 13 patients
with MCN and RF. This study was performed by indirect im-
munofluorescence using Mab specific for 3 different epitopes. THP
deposits were identified in 30 to 70% of GUS in 10 patients. They were
associated with interstitial deposits in 3 cases. They could not be found
in 9 patients with a monoclonal component and renal lesions different
from MCN (including amyloidosis, nodular glomerulosclerosis and
proliferative glomerulonephritis). In contrast, they were also detected
in 10 of 13 Balb/c mice bearing a K light—chain excreting plasmocytoma
(MOPC 41 or 66.2) which had developed lesion closely resembling
MCN. Since the presence of THP in glomeruli is attributed to retro-
grade flow of tubular urine, our results suggest that tubular obstruction
is frequent in MCN and plays a substantial role in the genesis of RF.
A clinico-pathological study of 34 myeloma patients with severe renal
failure (RE). S Rota, B Mougenot, F Mignon, V Lemaitre, E Rondeau,
Ph Vanhille, P Verroust, P. Ronco, Unite INSERM U64 and Services
de Nephrologie, Hópital Tenon, Paris, France, Valenciennes and
Bergamo, Italy. Severe RF occurring in the course of multiple myeloma
is often considered irreversible, therefore questioning the use of dialysis
in those patients affected with a fatal disease. The aim of the present
study was to reappraise the prognosis of RF in a series of 34 patients,
33 to 90 years old. RF was totally reversible in 7 patients (creatininemia
= 1035± 558 jiM/liter), partially reversible in 9 (1017 372 jiM/liter),
and irreversible in 18 (927 373 jiM/liter. The outcome was not linked
to age, type and isoelectric point of light chains, tumor mass and prior
duration of myeloma, nature of precipitating events or kidney size
(normal in 33 patients). It was more severe in females and appeared to










isolated TN infiltrate Fibrosis nephritis
This study shows a reduced 5 minute C3a generation—rate when PIV is
compared to PVC. CR1 and LTP, which do not induce DEHP toxic
blood contamination, do not induce, in our preliminary data, reduced
C3a generation. Unfortunately, Ply is known to release DHEP despite
the polyurethane "barrier." The interest of a biocompatible blood
tubing material may be controversial in conventional hemodialysis with
cuprophanR dialyzers, but the increasing use of biocompatible mem-
branes may enhance the relative role of blood tubings. Furthermore, the
complement activation by apheresis tubings, even with centrifugation
device, could be minimized by more biocompatible blood tubings.
Use of monoclonal antibodies (MAB) specific for Tamm—Horsfall
protein (THP) to probe tubular obstruction induced by myeloma casts. M
De Meyer, B Mougenot, B Baudouin, F Mignon, P Verroust, P Ronco.
Unite INSERM U64 and Service de Nephrologie, Hopital Tenon,
Paris; Service de Néphrologie, Clinique St Luc, Brussells, Belgium.
Myeloma cast nephropathy (MCN) is characterized by the presence of
numerous typical casts associated with tubular cell damage. The role of
cast—induced tubular obstruction in the development of renal failure
Complete recovery of RF, only observed in the absence of interstitial
damage, was associated with a mean survival time of 24 months. These
results justify renal biopsy and active treatment.
Tissular distribution of dialysis amyloidosis. LH Noel, J Zingraff, T
Bardin, C Atienza, D Kuntz, T Drüeke INSERM U.25 and U.90,
HôpitalNecker, Department of Nephrology, Paris, France. In order to
answer the question if dialysis associated amyloidosis which is com-
posed of /32-microglobulin (th-m) is a systemic disease, we examined
various tissues in 23 hemodialysis patients treated for a mean period of
11.7 years (range, 9 to 18). immunohistochemical evidence of th—m
amyloidosis localized in articular tissues or carpal tunnel synovium was
provided in 13 of 23 patients; clinical and X-ray findings made this
diagnosis very likely in 5 others. The material was obtained by needle
aspiration of abdominal fat (5 aspirates), by biopsy of the skin (9 cases)
or the bone (8 cases), or by autopsy (7 cases). All samples were studied
after Congo red staining under plain and polarizing light microscopy.
Congo red—positive samples were pretreated by potassium permangan-
ate and also processed for immunohistochemical studies. None of the
CGR 5 mm 15 mm 30 mm
19.4 15.51 17.2 9.40
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a Survival time less than 60 days.
Abstracts
fat aspirates or skin biopsies showed amyloid deposits. In only one of
the bone biopsies could a small Congo red—positive area be recognized
that showed characteristic birefnngence under polarizing light. Autopsy
material findings were negative except in one case; this patient had been
dialyzed for more than 18 years. Very minute th-m amyloid deposits
were found in small vessel walls in her lung, heart, liver and intestine.
In conclusion, accumulation of /32-m amyloid fibrils in tissues other
than joints and juxta-articular structures has a low incidence, occurs
late in long—term hemodialysis patients and is much less abundant than
in involved articulations. Although extra—articular amyloid deposits
may progressively occur with increasing survival on dialysis, the tiny
deposits observed in only one of our patients can hardly be considered
to lead to serious complications.
Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), decreases
proteinuria in some glomerular disease. A controlled study. J Laurent, D
Beighiti, C Bruneau, G Lagrue, Service de Nephrologie, Hôpital Henri
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Mondor, 94010 Créteil, France. NSAID treatment was first used in
chronic glomerulonephritis (CON) by Michielsen in 1966, but its
efficiency is still debated. We studied the antiproteinuric effect of such
a treatment in a double—blind study. Twenty—nine CON patients with
normal renal function (17 membranoproliferative GN, 12 IgA CON)
were randomly assigned to receive 100 mg/day of Diclofenac or placebo
for 2 to 3 months. Twenty—four hour proteinuria (mean of 3 determina-
tions) was assayed before and at the end of therapy. There was a
significant antiproteinuric effect of Diclofenac versus placebo, with a
fall of 70% in the Diclofenac group versus 6% in placebo (P < 0.001 with
Mann—Whitney test). The median was 2.2 mg/mm at onset and 0.95
mg/mm after 2 months' treatment for Diclofenac. For placebo, it was
respectively 3 and 2.45 mg/mm (P < 0.01). During treatment creatinine
levels remained unchanged. Gastric irritation was noted only once. This
study establishes the short—term antiproteinuric action of Diclofenac.
Whether this action will affect final outcome is not yet determined.
